---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-172997"
form_type: "8-K"
ticker: "LYEL"
cik: "0001806952"
company_name: "Lyell Immunopharma, Inc."
filed_at: "2022-06-13T23:59:59+00:00"
generated_at: "2026-06-25T02:26:59.510629+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lyell Immunopharma annual meeting elects Class I directors, ratifies auditor

## Summary
- Elected Hans Bishop, Catherine Friedman, Robert Nelsen as Class I directors; each received >147M votes for.
- Ratified Ernst & Young LLP as independent auditor for FY2022; 192.2M for, 1,241 against.
- Quorum achieved with 192,242,640 shares (77.79%) present at June 8, 2022 annual meeting.

## SEC filing metadata
- accession: 0001193125-22-172997
- form_type: 8-K
- ticker: LYEL
- cik: 0001806952
- company_name: Lyell Immunopharma, Inc.
- filed_at: 2022-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1806952/000119312522172997/0001193125-22-172997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1806952/000119312522172997/d357559d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-172997
- JSON: https://secwatch.observer/filing/0001193125-22-172997.json
- Plain text: https://secwatch.observer/filing/0001193125-22-172997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.